Skip to main content

Table 1 Clinical characteristics of the genotyped subjects in the ISOR study

From: The TCF7L2rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population

Parameter Non-T2D subjects T2D subjects p
  (n = 644) (n = 76)  
Age (years) 42.8 ± 9.6 52.0 ± 9.5 9.4 × 10−15
Weight (kg) 70.6 ± 14.6 75.6 ± 13.9 0.005
BMI (kg/m2) 25.8 ± 5.1 27.9 ± 5.2 0.001
Waist (cm) 86.4 ± 12.2 95.6 ± 10.9 5.8 × 10−10
Hip (cm) 101.7 ± 9.7 102.5 ± 11.0 0.53
Waist-to-hip ratio 0.85 ± 0.08 0.94 ± 0.11 9.0 × 10−17
Fasting glucose (mmol/L) 4.78 ± 0.49 9.58 ± 3.02 5.71 × 10−176
Fasting insulin (μIU/mL) 7.94 ± 5.67 11.34 ± 10.70 0.002
HOMA-IR 1.7 ± 1.2 4.7 ± 5.2 4.5 × 10−25
HOMA-B 144.7 ± 130.3 51.8 ± 55.9 6.8 × 10−37
Triglycerides (mmol/L) 1.11 ± 0.47 1.58 ± 0.70 4.4 × 10−11
Total cholesterol (mmol/L) 4.44 ± 0.90 4.54 ± 1.03 0.33
HDL-cholesterol (mmol/L) 1.26 ± 0.31 1.21 ± 0.30 0.17
LDL-cholesterol (mmol/L) 2.68 ± 0.85 2.67 ± 1.03 0.92
SBP (mmHg) 122.1 ± 17.2 133.6 ± 22.2 6.3 × 10−8
DBP (mmHg) 76.2 ± 9.9 81.1 ± 9.2 4.5 × 10−5
  1. Data are expressed as the mean ± standard deviation.